Clinical trials
Recruiting Phase 3 Neuroblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2 |
| Children's Oncology Group | 1 |
| National Cancer Institute (NCI) | 1 |
| St. Anna Kinderkrebsforschung | 1 |
| University of Alberta | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 6 |
| Ganglioneuroblastoma | 4 |
| Brain Neoplasms | 1 |
| Congenital Hyperinsulinism | 1 |
| Lewy Body Disease | 1 |
| Neuroendocrine Tumors | 1 |
| Parkinson Disease | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.